Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Servier
Biotech
Ideaya and Servier report eye cancer win, clearing path to FDA
The phase 2/3 trial hit its primary endpoint, teeing up a filing for accelerated FDA approval in the second half of the year.
Nick Paul Taylor
Apr 13, 2026 7:08am
Lilly embraces AI biotech Insilico again, inking $2.75B collab
Mar 29, 2026 8:00pm
Molecular glue biotech f5 Therapeutics closes down
Mar 10, 2026 1:10pm
Fierce Pharma
Servier rounds out rare cancer offerings with $2.5B Day One buy
Mar 6, 2026 10:14am
Biotech money moves: 3 new venture funds raise nearly $1B
Jan 9, 2026 1:20pm
Insilico pens potential $888M cancer R&D pact with Servier
Jan 4, 2026 7:30pm
